Incruse Ellipta and Medroxyprogesterone Injection (400 mg/mL)
Determining the interaction of Incruse Ellipta and Medroxyprogesterone Injection (400 mg/mL) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Medroxyprogesterone Injection (Intramuscular)
- Incruse Ellipta-Medroxyprogesterone Injection (Subcutaneous)
- Incruse Ellipta-Medroxyprogesterone Injection ER
- Incruse Ellipta-Medroxyprogesterone Intramuscular
- Incruse Ellipta-Medroxyprogesterone Tablets
- Incruse Ellipta-Medworx Patch
- Medroxyprogesterone Injection (400 mg/mL)-Indacaterol
- Medroxyprogesterone Injection (400 mg/mL)-Indacaterol and Glycopyrrolate
- Medroxyprogesterone Injection (400 mg/mL)-Indacaterol and glycopyrrolate Inhalation
- Medroxyprogesterone Injection (400 mg/mL)-Indacaterol inhalation
- Medroxyprogesterone Injection (400 mg/mL)-Indacaterol Maleate
- Medroxyprogesterone Injection (400 mg/mL)-Indapamide